<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59">
 <label>59.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Liebowitz</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Kasparek</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Pasetti</surname>
    <given-names>MF</given-names>
   </name>
   <name>
    <surname>Garg</surname>
    <given-names>SJ</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial</article-title>. 
  <source>JCI Insight.</source> (
  <year>2018</year>) 
  <volume>3</volume>:
  <fpage>e121077</fpage>. 
  <pub-id pub-id-type="doi">10.1172/jci.insight.121077</pub-id>
  <?supplied-pmid 29997294?>
  <pub-id pub-id-type="pmid">29997294</pub-id>
 </mixed-citation>
</ref>
